Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/214855
Genome-scale quantification and prediction of pathogenic stop codon readthrough by small molecules
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Premature termination codons (PTCs) cause ~10–20% of inherited diseases and are a major mechanism of tumor suppressor gene inactivation in cancer. A general strategy to alleviate the effects of PTCs would be to promote translational readthrough. Nonsense suppression by small molecules has proven effective in diverse disease models, but translation into the clinic is hampered by ineffective readthrough of many PTCs. Here we directly tackle the challenge of defining drug efficacy by quantifying the readthrough of ~5,800 human pathogenic stop codons by eight drugs. We find that different drugs promote the readthrough of complementary subsets of PTCs defined by local sequence context. This allows us to build interpretable models that accurately predict drug-induced readthrough genome-wide, and we validate these models by quantifying endogenous stop codon readthrough. Accurate readthrough quantification and prediction will empower clinical trial design and the development of personalized nonsense suppression therapies.
Matèries
Matèries (anglès)
Citació
Citació
TOLEDANO MARTIN, Ignasi, SUPEK, Fran, LEHNER, Ben. Genome-scale quantification and prediction of pathogenic stop codon readthrough by small molecules. _Nature Genetics_. 2024. Vol. 56, núm. 1914–1924. [consulta: 23 de gener de 2026]. ISSN: 1546-1718. [Disponible a: https://hdl.handle.net/2445/214855]